Sat, Jul 26, 2014, 11:45 AM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Boston Scientific Corporation Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • pet_detective78 pet_detective78 May 20, 2012 1:50 PM Flag

    This Msg Board Has A Liar (Ritchie).


    There are plenty of people out there who see you as a clueless pumper, quit accusing others of multiple screen names.

    You say the company has made "vast improvements"? Such as what? STJ and MDT are still stealing market share from them in CRM. Even with STJ's lead problems, STJ is still stealing market share from BSX. ABT and other companies have developed fully bioabsorbable stents, and ABT already has CE mark approval. BSX cannot compete against ABT in this aspect. Metal stents are on their way out, and BSX has failed to innovate and move onto the next generation of stents. The only way this company knows how to make money is through massive layoffs. I don't know about you, but I don't think having massive layoffs every year is a viable strategy to grow profits.

    Do you even know what an FDA approval entails? What do you mean by "full implemented"? Since you're from Mississippi, which is the poorest US state and the least educated US state, let's take a moment to educate you. Once the FDA approves something, you can start selling immediately. There is no implementation time or waiting period. Looking at BSX's new product approvals, the competition already has something better on the market. BSX is just a "me too" company with "me too" products. The FDA approval announcements are meaningless.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
13.11-0.15(-1.13%)Jul 25 4:02 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.